Clinical Trial Update: COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study [Phase 1]

View source ↗

Summary

Phase 1 pilot mechanistic study evaluating the effects of menopausal hormone replacement therapy on Metabolic Dysfunction Associated Steatotic Liver Disease in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• Menopausal Hormone Replacement Therapy (hormone replacement therapy)

Snippet

Sponsor: University of Oxford | Conditions: Menopause, Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 1 | Status: RECRUITING